Today

Agents

Chat

Arena

Discover

More

App

CTT Pharmaceutical CEO Ryan Khouri acquires 3,500 shares for $175 - CTTH News | Rallies

CTT Pharmaceutical CEO Ryan Khouri acquires 3,500 shares for $175

CTTH•2026-09-10

CEO share purchase

CTT Pharmaceutical CEO Ryan Khouri bought 3,500 CTTH shares at $0.05 each.
Directly held stake rose to 9,400,556 shares following the purchase.

Related News

Descartes Systems Q2 Adjusted EBITDA USD 94.4 Million Vs. IBES Estimate USD 91.6 Million

DSGX•2026-09-10

Barington Capital takes Bath & Body Works stake, pushes for sale, Bloomberg reports

BBWI•2026-09-10

Century Therapeutics director Joseph Truitt files initial beneficial ownership statement

IPSC•2026-09-10

Sources

S

CTT Pharmaceutical CEO Ryan Khouri acquires 3,500 shares for $175

Sec

Innventure CEO, director William J. Grieco files initial beneficial ownership statement

INNV•2026-09-10

Curtiss-Wright Corporation Expects Annual Share Repurchases Of $460 Million In 2026

CW•2026-09-10